OrganiGram Holdings Inc Asset Resilience Ratio
OrganiGram Holdings Inc asset resilience ratio. OrganiGram Holdings Inc (OGI) has an Asset Resilience Ratio of 0.16% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See OGI defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of OrganiGram Holdings Inc (2016–2025)
Asset resilience ratio of OrganiGram Holdings Inc from 2016 to 2025. This chart shows how OrganiGram Holdings Inc's Asset Resilience Ratio has changed over time. Read OGI current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down OrganiGram Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see OrganiGram Holdings Inc total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$811.00K | 0.16% |
| Total Liquid Assets | CA$811.00K | 0.16% |
Asset Resilience Insights
- Limited Liquidity: OrganiGram Holdings Inc maintains only 0.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
OrganiGram Holdings Inc Industry Peers by Asset Resilience Ratio
Compare OrganiGram Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
OrganiGram Holdings Inc Asset Resilience Ratio by Year (2016–2025)
OrganiGram Holdings Inc asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for OrganiGram Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 0.15% | CA$826.00K ≈ $597.52K |
CA$562.21 Million ≈ $406.69 Million |
-0.05pp |
| 2024-09-30 | 0.20% | CA$821.00K ≈ $593.90K |
CA$407.86 Million ≈ $295.04 Million |
-- |
| 2023-09-30 | 0.00% | CA$0.00 ≈ $0.00 |
CA$298.45 Million ≈ $215.90 Million |
-- |
| 2022-09-30 | 5.27% | CA$30.40 Million ≈ $21.99 Million |
CA$577.11 Million ≈ $417.47 Million |
-17.92pp |
| 2021-09-30 | 23.19% | CA$128.48 Million ≈ $92.94 Million |
CA$554.02 Million ≈ $400.77 Million |
+11.19pp |
| 2020-09-30 | 12.00% | CA$50.13 Million ≈ $36.26 Million |
CA$417.62 Million ≈ $302.10 Million |
+11.91pp |
| 2019-09-30 | 0.09% | CA$380.00K ≈ $274.89K |
CA$428.52 Million ≈ $309.99 Million |
-24.70pp |
| 2018-09-30 | 24.79% | CA$75.00 Million ≈ $54.25 Million |
CA$302.57 Million ≈ $218.87 Million |
-9.69pp |
| 2017-09-30 | 34.48% | CA$32.00 Million ≈ $23.15 Million |
CA$92.81 Million ≈ $67.14 Million |
-7.80pp |
| 2016-09-30 | 42.28% | CA$22.77 Million ≈ $16.48 Million |
CA$53.87 Million ≈ $38.97 Million |
-- |
About OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more